Clarity Pharmaceuticals
(ASX) CU6
Clarity Pharmaceuticals Financials at a Glance
Market Cap
$1.17B
Revenue (TTM)
$15.55M
Net Income (TTM)
$144.95M
EPS (TTM)
$-0.28
P/E Ratio
-11.21
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Price
$3.13
Volume
1,325,415
Open
$3.18
Price
$3.13
Volume
1,325,415
Open
$3.18
Previous Close
$3.13
Daily Range
$3.13 - $3.23
52-Week Range
$1.73 - $5.87
Dividend
$0.00
Beta (Volatility)
0.02 (Low)
Price
$3.13
Volume
1,325,415
Open
$3.18
Previous Close
$3.13
Daily Range
$3.13 - $3.23
52-Week Range
$1.73 - $5.87
CU6 News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clarity Pharmaceuticals
CU6 Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-21%
Net Income Margin
-20%
Return on Equity
-53%
Return on Capital
-44%
Return on Assets
-38%
Earnings Yield
-8.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.17B
Shares Outstanding
372.26M
Volume
1.33M
Short Interest
0.00%
Avg. Volume
2.29M
Financials (TTM)
Gross Profit
$9.46M
Operating Income
$69.09M
EBITDA
$68.91M
Operating Cash Flow
$54.77M
Capital Expenditure
$182.74K
Free Cash Flow
$54.95M
Cash & ST Invst.
$84.12M
Total Debt
$0.00
Clarity Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$150.62K
-105.7%
Gross Margin
0.00%
N/A
Market Cap
$1.17B
N/A
Market Cap/Employee
$23.30M
N/A
Employees
50
N/A
Net Income
$55.53M
-222.8%
EBITDA
$62.31M
-177.4%
Quarterly Fundamentals
Net Cash
$226.25M
+495.7%
Accounts Receivable
$16.81M
+9.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-37.65%
N/A
Return on Invested Capital
-43.61%
N/A
Free Cash Flow
$48.05M
-77.0%
Operating Cash Flow
$47.79M
-79.0%